AMGEN Inc
NASDAQ: AMGN
$282.87
+$2.80 (+1.0%)
Closing Price on November 29, 2024
AMGN Articles
These are ten of the top impact research calls with upgrades and downgrades from Wall Street early this Friday morning: Amgen (AMGN) Raised to Overweight at JPMorgan. ConocoPhillips (COP) Raised to...
Published:
Layoffs at big companies are so common now that it is novel when a day goes by without Microsoft (MSFT), Caterpillar (CAT), or Macy’s (MC) letting thousands of people go. There are a relatively...
Published:
Last Updated:
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know is if these results — or more importantly its guidance — show that this...
Published:
Last Updated:
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT reported that the world’s largest pharmaceutical company is willing to...
Published:
Last Updated:
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally you see a pattern. This month the only pattern seems to be one...
Published:
Today 24/7 Wall St.named its annual CEO of the Year James A. Skinner of McDonald’s (MCD). He was picked from a field of ten executives which we profiled over the last ten days. Skinner was chosen...
Published:
Last Updated:
24/7 Wall St. will name its annual CEO of the Year next week. The executive will be picked from a field of ten which we will profile this week The CEOs are chosen on the basis of their company’s...
Published:
Amgen Inc. (NASDAQ: AMGN) has just posted earnings. The biotech giant for anemia treatments posted $1.09 GAAP EPS and adjusted earnings of $1.23 non-GAAP EPS and $3.875 billion in revenues. First...
Published:
Last Updated:
These are some of the top upgrades we are seeing from Wall Street analysts this morning: Amgen (AMGN) Raised to Outperform at William Blair. Capital Product Partners (CPLP) Started as Outperform at...
Published:
According to Reuters, the federal government bailed out AIG (AIG) The Fed will loan the insurance company $85 billion for two years in exchange for a 79.9% stake. Reuters says that Barclays (BCS)...
Published:
Last Updated:
Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor. The short interest in Amgen (AMGN) dropped 22% and Calgene (CELG) fell 20%. “The Next NVIDIA”...
Published:
Last Updated:
These are some of the key analyst upgrades and positive calls we have seen early this Monday morning with over 2 hours to open: Akamai Tech (AKAM) Raised to Buy at Jefferies. Amgen (AMGN) Started as...
Published:
According to Reuters, T Boone Pickens is seeking an "army" of business leaders and citizens to back alternative energy. Reuters reports that Starbucks (SBUX) posted if first loss as a public company...
Published:
Last Updated:
These are some of the analyst upgrades and positive calls we are seeing early this Tuesday morning: Aeropostale (ARO) Started as Buy at Goldman Sachs. Amgen (AMGN) Raised to Buy at Citigroup. Dr....
Published:
Earnings out of Amgen Inc. (NASDAQ: AMGN) appear to be strong enough to defy any notions that the big osteoporosis news would render this particular earnings report immaterial. The biotech giant just...
Published:
Last Updated: